HOUSTON-based FibroBiologics, Inc. (NASDAQ:FBLG), a pharmaceutical company with a market capitalization of $56 million and a "WEAK" financial health score according to InvestingPro, has disclosed ...
Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.
As technology continues to evolve, the trajectory for MIS in ASCs remains positive. With continued innovation, procedural migration, and improved patient selection, the next decade is poised to bring ...
Hao Hong is the esteemed chairman of Asymchem Laboratories, a Shenzhen-listed company renowned for its pharmaceutical outsourcing services.
The global pharmaceutical market size is calculated at USD 1,772.65 billion in 2025 and is expected to reach around USD 3,033 ...
Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
Enric Bonet, Managing Director, Manvert: Investment still exists but not the willingness to pay the amounts being invested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results